Avalo Therapeutics, Inc. · NASDAQ:AVTX
BlackRock, Inc. reported a 6.50% stake in Avalo Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc. reported a 6.50% stake in Avalo Therapeutics, Inc., 3,415,731 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G).
- Stake
- 6.50%
- Shares
- 3,415,731
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.50% | 3,415,731 |